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Abstract
Objective To determine the relative importance of
environmental and genetic effects in the development
of rheumatoid arthritis.
Design Historical cohort study with record linkage
between a twin registry and the Danish discharge
registry as well as the Danish national registry of
deaths used to estimate completeness.
Setting Two population based nationwide twin birth
cohorts.
Participants 37 338 twins were sent a questionnaire
about rheumatic diseases. Self reported rheumatoid
arthritis was verified by clinical examination and from
medical records.
Main outcome measures The probandwise
concordance rate of rheumatoid arthritis in
monozygotic and dizygotic twins.
Results The response rate was 84.7%. Rheumatoid
arthritis was verified in 13 monozygotic and 36
dizygotic twins. There were no concordant
monozygotic twin pairs and two concordant dizygotic
twin pairs. Based on capture›recapture methods the
probability of ascertainment was 78.3%. The
probandwise concordance rate was 0 (95% confidence
interval 0 to 24.7) in monozygotic twins and 8.8 (1.9
to 23.7) in dizygotic twins.
Conclusion Genes are of minor importance in the
development of rheumatoid arthritis.
Introduction
Rheumatoid arthritis is a systemic inflammatory auto›
immune disease of unknown cause. Environmental
and genetic risk factors have been identified, but no
single risk factor has emerged as necessary or sufficient
to cause the disease.
Twin studies represent one of the simplest ways to
unravel the relative importance of genetic and
environmental effects. In studies of specific diseases or
traits in twins who volunteer to take part, monozygotic,
concordant, and female twins tend to be over›
represented.1 2 Hence, much of the available literature
on rheumatoid arthritis in twins overestimates the con›
tribution of genetic factors.3–5 Only two previous
studies were population based, but confirmation of the
diagnosis according to validated classification criteria
was not performed.1 6
We undertook a nationwide study among twins in
Denmark to estimate the importance of genetic effects
in the development of rheumatoid arthritis.
Methods
Ascertainment of twins
The study comprised two nationwide twin populations.
The older birth cohort comprised 1631 same sex pairs
of twins born 1921›40 in which both twins were alive in
1994.7 The younger birth cohort comprised 34 076
surviving twins from same and opposite sex pairs of
twins born 1953›82.7 To estimate a possible selection
bias introduced by the requirement that both twins had
to be alive we also sent questionnaires to 990 surviving
individuals from same sex twin pairs born 1921›30.
Ascertainment and verification of rheumatoid
arthritis
In 1994 the twins were asked by questionnaire if they
had ever suffered from rheumatoid arthritis. Twins who
reported that they had rheumatoid arthritis subse›
quently received a clinical profile questionnaire
followed by a telephone interview. If rheumatoid
arthritis could not be ruled out they were asked for
permission to approach their non›affected cotwin.
Both twins were invited to have a clinical examination.
They underwent a structured interview and clinical
examination, and blood samples were drawn for
measurement of rheumatoid factor, HLA typing, and
determination of zygosity.
All participants gave informed consent and
permission for us to collect information from medical
records. We used the modified 1987 revised criteria of
the American Rheumatism Association to confirm the
diagnosis.8 Time of onset was defined as the time when
the diagnosis was established for the first time accord›
ing to either the patient or a physician. Time of
discordance was defined as the time from onset in
one twin until onset in the second twin or the end of
observation.
Laboratory techniques
We established zygosity by blood group analysis.
Monozygotic twins are same sex pairs with complete
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blood group concordance; < 0.5% of dizygotic pairs
have this concordance.9 Genomic DNA was prepared
from peripheral blood lymphocytes and amplified by
polymerase chain reaction. We used sequence specific
primers for the detection of the currently recognisable
HLA alleles associated with rheumatoid arthritis,
which are characterised by one common epitope (the
shared epitope).10 We used enzyme linked immuno›
sorbent assay (ELISA) with human IgG as antigen to
detect the presence of rheumatoid factor.
Validation of completeness
We used record linkage with the Danish discharge reg›
istry to find any twins with rheumatoid arthritis that we
had not already identified. The record linkage included
twins discharged with a diagnosis of rheumatoid
arthritis since 1977, and the diagnosis was subse›
quently validated by examination of discharge papers
or telephone interview, or both. We estimated the com›
pleteness of the study with capture›recapture.11
We linked records of the twin registry and the Dan›
ish national registry of deaths to identify any twins with
rheumatoid arthritis who had died between 1951 and
1995. We sent a questionnaire to individual twins who
would have been eligible for participation except for
the death of their cotwin. The surviving twin was asked
whether he or she or the deceased cotwin had ever had
rheumatoid arthritis.
Ethics
The study was approved by all the regional scientific
ethics committees in Denmark and the Danish data
protection board.
Analysis
There are three different measures of concordance
used in twin studies. As there are always different
degrees of ascertainment only the probandwise
concordance rate should be used as it is robust against
incomplete ascertainment compared with the pairwise
and casewise concordance rates,12 13 which always tend
to inflate the importance of genetic factors. Thus, in
our study a proband was a twin who independently of
his or her cotwin reported rheumatoid arthritis and
who fulfilled our classification criteria for rheumatoid
arthritis. A secondary case was a twin ascertained
through a cotwin and who fulfilled our classification
criteria for rheumatoid arthritis. We excluded pairs of
twins who both had rheumatoid arthritis and neither
twin fulfilled the proband criteria.
We had four categories of twin pairs with at least
one affected member. Concordant pairs were classified
into one of four groups: pairs in which neither affected
twin fulfilled the proband criteria (C0); singly
ascertained concordant pairs—that is, one affected twin
was a proband and the other a secondary case (C1);
and doubly ascertained concordant pairs—that is, both
affected twins were probands (C2). For discordant pairs
the affected twin fulfilled the proband criteria (D1).
We calculated probandwise concordance rate as
(C1 + 2C2)/(C1 + 2C2 + D1) and pairwise concord›
ance rate as (C1 + C2)/(C1 + C2 + D1). All estimates
are given with 95% confidence intervals.
Results
The overall response rate after one reminder was 75%
(2445/3262) in older twins and 86% (29 433/34 076)
in younger twins. The response rate for both twins
from a pair was higher among monozygotic twin pairs
(4210/5194, 81%) than among dizygotic same sex
pairs (5129/6961, 74%) and dizygotic opposite sex
pairs (3769/5513, 68%). Slightly more women than
men responded (16 639/19 167 (87%) v 15 239/
18 575 (82%)). One hundred and fifty twins said they
had rheumatoid arthritis. At the telephone interview
62 had no signs of arthritis, eight did not respond, six
could not be traced, four declined to participate in a
clinical examination, and one had died. The 69
remaining twins, in addition to three twins recruited
through secondary sources, and 60 cotwins, agreed to a
clinical examination. The participating twins were
examined by AJS at home, at work, or in hospital. One
twin declined to donate a blood sample. From the 72
candidate cases, 49 satisfied the modified criteria of the
American Rheumatism Association (table 1).
Table 2 gives details of the twins with rheumatoid
arthritis. There were no significant differences between
monozygotic and dizygotic twins regarding sex, age,
age at onset, mean discordance time, presence of rheu›
matoid factor, bony erosions, or shared epitope.
Nodules were present more often in monozygotic
twins than in dizygotic twins.
In one dizygotic twin pair, the twin with self
reported rheumatoid arthritis was not affected,
whereas the cotwin, who had not reported having
rheumatoid arthritis, did fulfil the classification criteria
for rheumatoid arthritis. As this pair was not presented
by a proband we excluded them from the analysis.
Table 3 shows the probandwise and pairwise concord›
ance rates. There was no difference between mono›
zygotic and dizygotic twin pairs in the rates. The
probandwise concordance rate was 0 (95% confidence
Table 1 Number of criteria for rheumatoid arthritis* present in
cohort of twins
No of criteria† No (%) of twins Cumulative No (%) of twins
7 2 (2.8) 2 (2.8)
6 16 (22.2) 18 (25.0)
5 19 (26.4) 37 (51.4)
4 12 (16.7) 49 (68.1)
3 6 (8.3) 55 (76.4)
2 11 (15.3) 66 (91.7)
1 5 (6.9) 71 (98.6)
0 1 (1.4) 72 (100.0)
*American Rheumatism Association 1987 revised criteria.
†To be classfied as having rheumatoid arthritis patients had to fulfil four or
more criteria.
Table 2 Distribution of demographic and clinical data in cases of twins with rheumatoid
arthritis according to zygosity. Figures are numbers (percentage) of individuals unless
stated otherwise
Characteristic
Monozygotic
(n=13) Dizygotic (n=36) 95% CI for difference
Women 9 (69.2) 25 (69.4) −29.5% to 29.0%
Mean (SD) age (years):
Older cohort (born 1921›40) 68.0 (2.7) 67.2 (3.3) −1.9 to 3.5
Younger cohort (born 1953›82) 31.2 (5.8) 35.1 (5.1) −10.0 to 2.2
Mean (SD) age at onset (years) 40.5 (20.7) 44.1 (15.1) −14.4 to 7.4
Mean (SD) discordance time (years) 13.3 (13.4) 13.7 (10.87) −8.0 to 7.3
Ever positive for rheumatoid factor 12 (92.3) 29 (80.6) −7.7% to 31.2%
Ever had erosions 9 (69.2) 24 (66.7) −26.9% to 32.0%
Ever had nodules 10 (76.9) 15 (41.7) 7.3% to 63.3%
Positive for shared epitope* 9 (69.2) 26 (74.3) −34.0% to 23.9%
*Known for 35 dizygotic twins as one dizygotic twin pair refused to give blood samples.
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interval 0 to 24.7) in monozygotic twins and 8.8 (1.9 to
23.7) in dizygotic twins.
The record linkage study identified 46 twins with
possible rheumatoid arthritis, but in 23 cases the diag›
nosis could not be verified. Among the remaining 23
twins, we had already identified 18 and identified five
solely through the Danish discharge registry. On the
basis of the capture›recapture model our question›
naire had an estimated probability of ascertainment of
78.3%, and hence nine cases (95% confidence interval
3 to 16) may have been missed. We found no concord›
ant monozygotic pairs through the Danish discharge
registry.
The response rate from twins whose cotwin had
died was 73.5%. There was no difference in response
rate between monozygotic and dizygotic twins nor
between men and women. Table 4 shows pairwise con›
cordance because twin pairs in which one twin had
died cannot fulfil the proband criteria. There was no
difference in concordance for rheumatoid arthritis
between monozygotic and dizygotic twin pairs.
From the record linkage study with the registry of
deaths we identified six twins from six different twin
pairs. In three cases the cotwins of the dead twins who
had had rheumatoid arthritis were still alive and
responded to the questionnaire. In one case a dizygotic
twin pair was concordant for rheumatoid arthritis
according to self report. We found no monozygotic
concordant pairs.
Discussion
In this large twin study monozygotic twins were no
more likely to be concordant for rheumatoid arthritis
that dizygotic twins. Our results do not support a
genetic contribution to the development of rheuma›
toid arthritis.
This is the first study to combine the recruitment of
twins with rheumatoid arthritis through a question›
naire sent to a population based random sample with a
subsequent clinically based validation of the diagnosis.
We may not have found some concordant twin pairs
with rheumatoid arthritis. Among pairs of twins in
which one twin had died we found four pairs of mono›
zygotic twins and three pairs of dizygotic twins who
were concordant for self reported disease. The positive
predictive value of self reported rheumatoid arthritis,
however, is less than one third14 15—that is, of people
who claim to have rheumatoid arthritis only one in
three will actually have it—and the report of disease on
behalf of family members is probably less accurate. It is
therefore unlikely that the exclusion of pairs in which
one twin had died had any impact on our results. The
record linkage between the twin registry and both the
national discharge registry and the national register of
deaths identified no concordant monozygotic twin
pairs and only one possible concordant dizygotic twin
pair. Using these alternative and independent recruit›
ment sources we found no monozygotic concordant
pairs among non›responders or dead twins.
Cross sectional studies cannot show the lifetime risk
for cotwins, but this does not imply any bias as long as
the mean and distribution of discordance time does not
differ between monozygotic and dizygotic twins, as in
our study. None of the previously published twin studies
on rheumatoid arthritis have dealt with this potential
bias. The association between rheumatoid arthritis and
HLA markers is related to age at onset and sex.16 17 We
did not find any difference in age at onset and sex
between monozygotic and dizygotic probands, though
rheumatic nodules, an indicator of more severe disease,
were more common in monozygotic twins. The UK
rheumatoid arthritis twin study is the only other such
study that can reject this potential bias.5 Even though our
study was population based, twins with rheumatoid
arthritis did not differ from twins recruited from clinical
settings with regard to the traditional measures of sever›
ity, including HLA associated antigens.
The lack of concordant pairs could be due to
observer bias, but this is unlikely as the cotwins in pairs
discordant for disease did not show any signs of arthri›
tis, and in most cases disease classification was based on
medical records and blood samples, both of which are
resistant to observer bias. We identified only a small
number of twins with rheumatoid arthritis because
participants were mostly young, with 90% of the twins
born in 1952›83.
Our study had an estimated probability of
ascertainment of 78%. As there is always bias in ascer›
tainment towards monozygotic twin pairs and twin
pairs concordant for specific diseases and traits,
complete ascertainment would not change our
estimate of concordance for rheumatoid arthritis.
Comparison with other studies
The Australian twin study was based on self reported
rheumatoid arthritis without a clinical examination,
and the sample of twins with rheumatoid arthritis had
a high monozygotic:dizygotic ratio of 1.56 with an
expected ratio of 0.5.4 Only the pairwise concordance
rates were presented.
The latest study of rheumatoid arthritis in twins in
the United Kingdom included only volunteers.5 In the
United Kingdom for every pregnancy resulting in a
live birth about one in 90 is of twins so on average
about two in 90 people will be twins.18 The prevalence
of rheumatoid arthritis is 1%, so an estimated 19
monozygotic and 39 dizygotic pairs in would be
concordant for rheumatoid arthritis simply by chance.
The UK study identified 14 monozygotic and four
dizygotic twin pairs concordant for rheumatoid arthri›
tis, suggesting ascertainment bias towards mono›
zygotic concordant pairs.
Table 3 Probandwise and pairwise concordance rates* (95%
confidence interval) of rheumatoid arthritis in twins according to
zygosity
Zygosity Probandwise Pairwise
Monozygotic 0 (0 to 24.7) 0 (0 to 24.7)
Dizygotic 8.8 (1.9 to 23.7) 5.9 (0.7 to 19.7)
*No difference in probandwise concordance rate between monozygotic and
dizygotic twins (95% CI −0.7 to 18.4).
Table 4 Rate of concordance for self reported rheumatoid arthritis in twin pairs in
which one twin had died
Zygosity Concordant Discordant Pairwise concordance rate (95% CI)*
Monozygotic 4 10 28.6% (8.4% to 58.1%)
Dizygotic 3 27 10.0% (2.1% to 26.5%)
Unknown 1 10 —
Total 8 47 —
*Difference in rate between monozygotic and dizygotic pairs was 28.9% (3.7% to 61.5%).
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Two previous rheumatoid arthritis twin studies
used a population based approach. In the Danish study
from 1965 classification of rheumatoid arthritis was
based on self report only.1 In the Finnish twin study the
diagnosis was based on the attending physician and
not verified.6 Thus, patients with, for example, ankylos›
ing spondylitis might have been included, and in addi›
tion cotwins might have been diagnosed with
rheumatoid arthritis on a less stringent basis if the
index twin had already been diagnosed.
We acknowledge that our sample was relatively
small, but we consider our results to be the most unbi›
ased estimate of the genetic contribution to rheuma›
toid arthritis and support the observation of a weak
familial aggregation.19 20 Genetic makeup seems of
minor importance in the development of rheumatoid
arthritis.
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Commentary: Do genes or environment influence development of
rheumatoid arthritis?
Alan J Silman
The aetiology of rheumatoid arthritis, like several other
chronic disorders, is widely accepted to be “multifacto›
rial.” This term suggests that the disease results from
one or more environmental influences acting on a
genetically susceptible background. Although the rela›
tive contributions of genetic and environmental
influences are the source of several investigations, in
the strictest sense, as with most other diseases, neither
is enough on its own to explain onset of the disease.
The size of a genetic effect is typically estimated
from the familal risk of recurrence, defined as the
increased risk in first degree relatives of affected
individuals compared with the background occurrence
in the population. With this approach the genetic con›
What is already known on this topic
Rheumatoid arthritis is a multifactorial disease
determined by both genetic and environmental
factors
Previous twin studies have shown a higher
concordance for rheumatoid arthritis in
monozygotic than in dizygotic twins, but the
results have been biased in favour of genetic
effects
What this paper adds
As concordance for rheumatoid arthritis in this
study was no more common in monozygotic twins
than in dizygotic twins environmental effects may
be more important than genetic effects in the
development of rheumatoid arthritis
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tribution to rheumatoid arthritis is indeed small. The
risk of recurrence in a sibling is possibly not much
greater than 2,1 substantially lower than that seen, for
example, with other autoimmune disorders such as
multiple sclerosis and thyroid disease.2 An extension to
that approach is to consider the comparative risk
between identical and non›identical cotwins of affected
individuals. The underlying hypothesis is that identical
(monozygotic) and (same sex) non›identical (dizygotic)
twins are similar in their sharing of the environment
and hence the magnitude of any excess risk of disease
in the monozygotic twins quantifies the genetic effect.
Two nationwide twin studies, one from Finland,3
the other from the United Kingdom,4 yielded similar
concordance rates in monozygotic twins of around
15% four times greater than that seen in dizygotic
twins. Indeed, from these two studies it was estimated
that shared genetic factors in the monozygotic twins
explained about 60% of the incidence of rheumatoid
arthritis.5 The assumption about similarity in environ›
ment between the two types of twins might not be true,6
and hence this proportion represents the upper limit.
Against this background the results of Svendsen et
al seem somewhat surprising. In this carefully
conducted investigation with a national twin register
they found no concordant monozygotic pairs and two
concordant dizygotic pairs. The authors conclude that
their data argue against a major genetic influence.
There are some limitations in their interpretation.
Small numbers and consequently wide confidence
intervals mean that their results are not inconsistent
with those from previously published studies. Also, the
authors relied on recalled diagnosis that might have
underestimated the true occurrence of the disease.
There is an undoubted genetic contribution to
rheumatoid arthritis which, at least in part, is explained
by a susceptibility allele at the HLA›DRB1 locus.7
Indeed, possession of susceptibility alleles at this locus
explains why some monozygotic twins are, and others
are not, concordant for rheumatoid arthritis.8 HLA,
however, may explain only about half of the genetic
contribution to rheumatoid arthritis,9 although it has
been a difficult task to show genetic susceptibility
factors other than HLA consistently among studies.10 11
In summary the study by Svendsen et al cannot dis›
prove a genetic component in susceptibility to
rheumatoid arthritis. However, their results emphasise
that the genetic effects are weak compared with
environmental ones in explaining differences in occur›
rence of the disease. This makes the task more difficult
for those attempting large scale linkage studies aimed
at revealing the genetic basis for rheumatoid arthritis.
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